Session 3-2-F: A Game-Theoretic Analysis of Baccara Chemin de Fer

Baccara chemin de fer — review of main contributions Baccara was first mentioned in print by Van Tenac in 1847. It was analyzed by Dormoy in 1872 and Bertrand in 1889. Borel called Bertrand’s study “extremely incomplete,” but it motivated Borel to develop game theory in the 1920s. Von Neumann planned to study baccara after proving the minimax theorem in 1928, but he didn’t. The first game-theoretic solution was by Kemeny and Snell in 1957. In 1964, Foster gave a solution based on a new algorithm, unaware of the Kemeny–Snell solution. A solution under more realistic assumptions was found by Downton and Lockwood in 1975 using Foster’s algorithm. Based on the extensive form of the game, the Kemeny–Snell solution was rederived by Deloche and Oguer in 2007

Composition and Self-Adaptation of Service-Based Systems with Feature Models

The adoption of mechanisms for reusing software in pervasive systems has not yet become standard practice. This is because the use of pre-existing software requires the selection, composition and adaptation of prefabricated software parts, as well as the management of some complex problems such as guaranteeing high levels of efficiency and safety in critical domains. In addition to the wide variety of services, pervasive systems are composed of many networked heterogeneous devices with embedded software. In this work, we promote the safe reuse of services in service-based systems using two complementary technologies, Service-Oriented Architecture and Software Product Lines. In order to do this, we extend both the service discovery and composition processes defined in the DAMASCo framework, which currently does not deal with the service variability that constitutes pervasive systems. We use feature models to represent the variability and to self-adapt the services during the composition in a safe way taking context changes into consideration. We illustrate our proposal with a case study related to the driving domain of an Intelligent Transportation System, handling the context information of the environment.Work partially supported by the projects TIN2008-05932, TIN2008-01942, TIN2012-35669, TIN2012-34840 and CSD2007-0004 funded by Spanish Ministry of Economy and Competitiveness and FEDER; P09-TIC-05231 and P11-TIC-7659 funded by Andalusian Government; and FP7-317731 funded by EU. Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tec

Training Graduate Students in Utilization of Analytical Instruments in a Failure Analysis Course

Department of Engineering Technology at University of North Texas offers a graduate course on failure analysis (MSET 5150) during spring semesters. Partial requirement for the course is for students to submit a term paper based on their collected data related to a term project. Case studies are given to groups of students to work on actual failed components received from area industries. Results of their findings are presented at the end of the semester in both oral presentation form and written term paper form followed the format of a well-established technical papers. Results of such exercises allows graduate students devote skills in using scientific instruments and practice manuscript preparations for publication. This paper presents examples of a case studies done by groups of students who worked on failure analysis of components failed in an oil and gas industry. Students developed skills in utilization of scanning electron microscope (SEM), Energy Dispersive Spectroscopy (EDS), and Fourier Transform Infrared Spectrophotometry. This exercise has proven highly effective in introducing young engineers to real world problems in oil and gas industry and help them develop skills needed in performing failure analysis and steps involved.Cockrell School of Engineerin

The role of MIF in chronic lung diseases:Looking beyond inflammation

Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that has been associated with many diseases. Most studies found in literature describe MIF as a proinflammatory cytokine involved in chronic inflammatory conditions, but evidence from last years suggests that many of its key effects are not directly related to inflammation. In fact, MIF is constitutively expressed in most human tissues and in some cases in high levels, which does not reflect the pattern of expression of a classic proinflammatory cytokine. Moreover, MIF is highly expressed during embryonic development and decreases during adulthood, which point toward a more likely role as growth factor. Accordingly, MIF knockout mice develop age-related spontaneous emphysema, suggesting that MIF presence (e.g., in younger individuals and wild-type animals) is part of a healthy lung. In view of this new line of evidence, we aimed to review data on the role of MIF in the pathogenesis of chronic lung diseases

Artemisinin Derivatives Stimulate DR5-Specific TRAIL-Induced Apoptosis by Regulating Wildtype P53

Artemisinin derivatives, widely known as commercial anti-malaria drugs, may also have huge potential in treating cancer cells. It has been reported that artemisinin derivatives can overcome resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in liver and cervical cancer cells. In our study, we demonstrated that artesunate (ATS) and dihydroartemisinin (DHA) are more efficient in killing colon cancer cells compared to artemisinin (ART). ATS/DHA induces the expression of DR5 in a P53 dependent manner in HCT116 and DLD-1 cells. Both ATS and DHA overcome the resistance to DHER-induced apoptosis in HCT116, mainly through upregulating death receptor 5 (DR5). We also demonstrate that DHA sensitizes HCT116 cells to DHER-induced apoptosis via P53 regulated DR5 expression in P53 knockdown assays. Nevertheless, a lower effect was observed in DLD-1 cells, which has a single Ser241Phe mutation in the P53 DNA binding domain. Thus, the status of P53 could be one of the determinants of TRAIL resistance in some cancer cells. Finally, the combination treatment of DHA and the TRAIL variant DHER increases cell death in 3D colon cancer spheroid models, which shows its potential as a novel therapy